Endoscopic Balloon Dilation for Crohn's Strictures Guide

This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before making any changes to your treatment plan.
If you have been told you have a stricture - a narrowed segment of your bowel - you are not alone, and surgery is not always the only option. Endoscopic balloon dilation for Crohn's strictures has become an important minimally invasive tool that can relieve obstruction, reduce symptoms, and help preserve precious bowel length. Understanding the success rates, risks, and who benefits most from this procedure can help you have a more confident conversation with your gastroenterologist about the path forward.
Key Takeaways
- A 2024 meta-analysis of 26 studies and 1,570 patients found a pooled technical success rate of 87.6% for balloon-assisted enteroscopy dilation of Crohn's small bowel strictures (2).
- Clinical or therapeutic success after small bowel endoscopic balloon dilation was 69.7%, with about 25% of patients eventually needing surgery (2).
- Being in endoscopic remission and on biologic therapy at the time of dilation significantly lowered the need for later surgery, according to a 2024 systematic review of 29 studies (1).
- The major complication rate is approximately 5.5% per procedure, including a perforation rate of about 2.7% and bleeding of about 2.5% (2).
- Short strictures under 5 cm without fistulas or abscesses are the best candidates for balloon dilation rather than surgery.

What Are Crohn's Strictures and Why They Form
A stricture is a narrowed segment of the bowel caused by a combination of chronic inflammation, scar tissue buildup, and muscle wall thickening (5). According to the Crohn's and Colitis Foundation, intestinal obstruction from strictures is the most common complication of Crohn's disease, occurring most often at the terminal ileum and ileocecal valve (5). Up to a third of Crohn's patients develop strictures within 10 years of diagnosis, making this one of the most common reasons a patient is referred for either a procedure or surgery (5).
Inflammatory vs Fibrotic Strictures
Not all strictures are created equal, and the distinction matters for treatment decisions. Inflammatory strictures are driven by active disease and may respond to medications such as biologics or immunomodulators. Fibrotic strictures, on the other hand, are composed primarily of scar tissue - mechanical narrowing that medications cannot reverse. In practice, many strictures involve a mix of both inflammation and fibrosis, which is one reason imaging and endoscopy before treatment are so important.
Common Locations: Terminal Ileum, Ileocolonic Anastomosis, Colon
Strictures most commonly form in the terminal ileum (the last portion of the small intestine), at an ileocolonic anastomosis (the surgical join after a prior bowel resection), and less frequently in the colon. Anastomotic strictures - narrowing at a prior surgical site - are particularly common and are often very well suited to balloon dilation because they tend to be short and accessible.
The symptoms that point toward a stricture include cramping after meals, nausea or vomiting, audible gurgling sounds, unintended weight loss, and episodes of partial bowel obstruction. If these sound familiar, your gastroenterologist may already be considering imaging to investigate.
What Endoscopic Balloon Dilation Actually Is
Endoscopic balloon dilation (EBD) is a minimally invasive procedure that uses a deflated balloon catheter passed through an endoscope to physically stretch open a narrowed segment of bowel. The balloon is positioned across the stricture and gradually inflated to a target diameter, typically 18 to 20 mm, widening the passage so food and fluids can move through more freely. The procedure is usually performed as an outpatient under sedation and takes roughly 30 to 60 minutes.
How the Procedure Works Step by Step
During a colonoscopy or enteroscopy, your gastroenterologist identifies the stricture visually and then passes a through-the-scope (TTS) balloon catheter across the narrowing. The balloon is inflated slowly, often in stages, using a controlled syringe filled with diluted contrast dye so the dilation can be monitored on fluoroscopy in real time. The balloon is typically held inflated for 30 to 60 seconds, then deflated. Your doctor may inflate it a second or third time if the stricture requires more gradual stretching.
Most patients can eat the same evening and return to normal activities within 24 to 48 hours.
Where It Can Reach: Colonoscope vs Balloon-Assisted Enteroscopy
A standard colonoscope can reach strictures in the colon, rectum, and terminal ileum. But many Crohn's strictures occur deeper in the small bowel, beyond the reach of a colonoscope. This is where balloon-assisted enteroscopy (BAE) comes in - either double-balloon or single-balloon enteroscopy - which allows the endoscopist to advance much further into the jejunum or proximal ileum (2). The 2024 meta-analysis by Moond and colleagues specifically examined outcomes of balloon dilation performed via balloon-assisted enteroscopy, confirming it as a viable approach for small bowel strictures that would otherwise require surgical intervention (2).
Who Is a Good Candidate for EBD
The strongest candidates for endoscopic balloon dilation are patients with short strictures - generally under 5 cm in length - that are single rather than multiple, without active deep ulceration, and without an associated fistula or abscess (3, 4). Anastomotic strictures after a prior bowel resection are particularly good targets because they tend to be short, accessible, and fibrotic.
Stricture Characteristics That Predict Success
Several factors predict a better outcome with EBD. Shorter length is consistently the most important. Strictures that are straight rather than angulated, and those located in areas the endoscope can reach comfortably, tend to respond well. A 2024 systematic review of 29 studies and 1,632 patients found that patients who were in endoscopic remission and receiving biologic therapy at the time of dilation had a significantly lower likelihood of needing surgery later (1). This underscores the importance of optimizing your medical therapy alongside any procedural intervention.
When Surgery Is the Better First Option
Balloon dilation is not appropriate for every stricture. Long strictures (over 5 cm), multiple strictures in sequence, strictures with sharp angulation, and strictures associated with a fistula or abscess generally require a surgical approach (4). In these situations, strictureplasty (a bowel-preserving surgical technique) or resection (removing the affected segment) may offer a more durable solution with a single procedure rather than repeated dilations.
The decision between EBD and surgery is not always straightforward, and a thoughtful conversation with both your gastroenterologist and a colorectal surgeon experienced in IBD can help you weigh the options for your specific situation.

How Well Does It Work: Success Rates and Outcomes
For patients considering EBD, the natural first question is: does it actually work? The evidence is encouraging, though it is important to understand what "success" means in this context - and what the realistic long-term picture looks like.
Technical and Symptom Success
A 2024 meta-analysis of 26 studies involving 1,570 patients reported a pooled technical success rate of 87.6% for balloon-assisted enteroscopy dilation of Crohn's small bowel strictures (2). Technical success means the balloon was successfully deployed and the stricture was dilated to the target diameter. Clinical or therapeutic success - meaning the patient experienced meaningful symptom improvement - was 69.7% in the same analysis (2). The gap between technical and clinical success reflects the reality that some patients may have additional disease factors contributing to their symptoms beyond the stricture itself.
Long-Term: Surgery-Free Survival and Recurrence
About 25% of patients eventually need surgery after small bowel EBD, and roughly 24% require at least one repeat dilation (2). Across older cohort studies, 42 to 70% of patients need either repeat EBD or surgery within 5 years (4). These numbers may sound discouraging at first, but context matters. Each successful dilation defers surgery and preserves bowel length - a critical consideration for Crohn's patients who may face multiple operations over a lifetime. For many patients, buying time with EBD while optimizing biologic therapy is a sound strategy.
Risks and Complications Patients Should Know About
Like any procedure, endoscopic balloon dilation carries risks. Understanding them honestly is part of making a well-informed decision.
Perforation, Bleeding, and Hospitalization
The major complication rate is approximately 5.5% per procedure for small bowel EBD (2). The two primary risks are perforation (a small tear through the bowel wall) at about 2.7% per procedure, and significant bleeding at about 2.5% per procedure (2). Most perforations are small and can often be managed with endoscopic clips, antibiotics, and a short hospital stay. Occasionally, emergency surgery is needed to repair a perforation, but this is uncommon.
How Risk Is Minimized
Experienced endoscopists minimize risk by inflating the balloon gradually, using fluoroscopic guidance, and carefully selecting patients whose strictures are appropriate for the procedure. A 2024 systematic review also noted that steroid use at the time of dilation was associated with a higher likelihood of needing surgery later, suggesting that the timing of the procedure relative to active disease management matters (1). Being on stable biologic therapy rather than steroids at the time of dilation appears to be associated with better long-term outcomes.
What to Expect Before, During, and After the Procedure
Knowing the practical details can take some of the anxiety out of the process.
Imaging and Pre-Procedure Workup
Before EBD, your team will order imaging to map the stricture and rule out complications like fistulas or abscesses. This typically involves MR enterography or intestinal ultrasound, both of which provide detailed views of the bowel wall and surrounding tissue. Blood tests and possibly a fecal calprotectin may also be checked to assess your current disease activity.
Bowel preparation is similar to what you would do for a colonoscopy - a clear liquid diet and a laxative solution the day before. Your medications and biologics are generally continued unless your team advises otherwise.
Recovery and Follow-Up Plan
Most patients go home the same day. You can usually eat a soft diet the same evening, and normal meals within a day or two. Restricted physical activity for 24 to 48 hours is typical.
Plan for a follow-up clinic visit within a few weeks. Your doctor may discuss whether a planned repeat dilation 4 to 8 weeks later is part of the strategy - some centers use a staged approach for tighter strictures. In the weeks after the procedure, track your symptom improvement: bloating, post-meal pain, and weight changes are the most useful markers. Report any new onset of sharp abdominal pain, fever, or blood in the stool urgently, as these could signal a complication.
How EBD Fits Into the Bigger Picture of Crohn's Care
Endoscopic balloon dilation does not exist in isolation. It is one tool in a broader toolkit that includes medical therapy, strictureplasty, and bowel resection - and the best outcomes come from combining these approaches thoughtfully.
EBD vs Strictureplasty vs Resection
The ENDOCIR randomized trial, launched in Spain in 2023, is directly comparing endoscopic treatment with surgical resection for de novo fibrotic Crohn's strictures shorter than 10 cm, using quality of life as the primary endpoint (3). This trial should provide much-needed head-to-head data to guide clinical decisions. Until those results are available, the choice between EBD, strictureplasty (a bowel-preserving surgical technique that widens the narrowed segment without removing it), and resection depends on the stricture characteristics, your surgical history, and how much bowel has already been lost.
For patients who have already had prior resections, preserving bowel length becomes increasingly important. If a stricture forms at an anastomotic site after surgery, EBD is often the preferred first approach because it avoids another resection and the associated risk of short bowel syndrome.
Combining EBD with Medical Therapy
The evidence increasingly supports the idea that EBD works best when combined with optimized medical therapy. Being on biologic therapy at the time of dilation was associated with better long-term outcomes and a lower need for surgery in the 2024 systematic review (1). This makes intuitive sense: the balloon opens the stricture mechanically, but if underlying inflammation continues unchecked, scar tissue will re-form and the stricture will recur. Your gastroenterologist may adjust your biologic dose or add a medication to address any residual inflammatory component before or after the procedure.
Shared decision-making with a gastroenterologist and surgeon - ideally at a center experienced in interventional IBD endoscopy - gives you the best chance of choosing the right approach for your specific situation.
Frequently Asked Questions
Is endoscopic balloon dilation safe for Crohn's patients?
For appropriately selected patients with short, accessible strictures and no associated fistula or abscess, EBD has a major complication rate of approximately 5.5% per procedure (2). The most common serious complications are perforation (2.7%) and significant bleeding (2.5%). Most complications can be managed without surgery. Your endoscopist will assess your stricture characteristics to determine whether EBD is a safe option for you.
How long does symptom relief last after balloon dilation?
Symptom relief varies. Clinical success is achieved in about 70% of patients initially (2), but roughly 24% need a repeat dilation and about 25% eventually require surgery (2). Some patients enjoy years of relief from a single dilation, while others need periodic repeat procedures. Maintaining effective biologic therapy after the procedure improves long-term outcomes (1).
Can balloon dilation replace surgery for Crohn's strictures?
In many cases, EBD can defer or replace surgery, especially for short strictures under 5 cm at accessible locations (3, 4). However, it is not a substitute for surgery when strictures are long, multiple, angulated, or complicated by fistulas or abscesses. The ENDOCIR trial is currently comparing the two approaches directly (3). For many patients, EBD buys valuable time while preserving bowel length.
How many times can a stricture be dilated?
There is no strict limit. Many patients undergo two or three dilations over several years. However, if a stricture recurs repeatedly and quickly despite optimal medical therapy, your team may recommend surgical intervention as a more definitive solution. The decision to repeat EBD versus proceed to surgery is individualized based on symptom response, stricture characteristics, and your overall treatment goals.
What should I ask my doctor about balloon dilation?
Useful questions include: How long is my stricture, and is it fibrotic, inflammatory, or mixed? Is my current biologic therapy optimized? What is the expected technical success rate for my specific stricture? Would a staged approach with a planned repeat dilation be appropriate? And should I see both a gastroenterologist and a surgeon before deciding on the best approach?
Does insurance cover endoscopic balloon dilation?
In most countries with public healthcare systems, EBD is covered when medically indicated. In the United States, most insurance plans cover the procedure as a medically necessary intervention. However, coverage details, pre-authorization requirements, and out-of-pocket costs vary by plan and by country. Contact your insurance provider or hospital billing department before the procedure to understand your specific coverage.
Is this procedure available everywhere?
EBD with a colonoscope is widely available at hospitals with gastroenterology departments. However, balloon-assisted enteroscopy for deeper small bowel strictures requires specialized equipment and expertise that may only be available at larger academic or tertiary care centers. If your stricture is in the small bowel beyond the reach of a colonoscope, ask for a referral to a center experienced in interventional IBD endoscopy.
References
- Nascimento Filho, et al. Patient-Related Factors Associated With Long-Term Outcomes After Successful Endoscopic Balloon Dilation For Crohn's Disease-Associated Ileo-Colic Strictures: A Systematic Review and Meta-analysis. Crohn's & Colitis 360, 2024. Read study
- Moond, et al. Endoscopic dilation of small-intestine strictures in Crohn's disease by balloon-assisted enteroscopy: a systematic review and meta-analysis. Annals of Gastroenterology, 2024. Read study
- Endoscopic treatment vs surgical resection for the treatment of de novo stenosis in Crohn's disease (ENDOCIR study): an open-label, multicentre, randomized trial protocol. 2023. Read study
- Stenke, Bourke, Knaus. Crohn's Strictures - Moving Away from the Knife. Frontiers in Pediatrics, 2017. Read study
- Crohn's & Colitis Foundation. Intestinal Complications fact sheet. 2024. Read article
Recommended Resources
Browse ResourcesRelated Articles

Vaccines for Crohn's Disease: What Patients Need to Know
Vaccines for Crohn's disease patients matter most before you start biologics. Learn which shots are safe, which ones to avoid, and how to time them right.

Preventing Postoperative Crohn's Recurrence: 2026 Guide
Up to half of Crohn's patients face endoscopic recurrence within a year of surgery. Learn 2026 evidence-based ways to prevent postoperative recurrence.

Capsule Endoscopy for Crohn's Disease: A Patient Guide
Capsule endoscopy for Crohn's disease uses a tiny swallowable camera to image the entire small bowel. Learn how PillCam works, what to expect, and the risks.

MR Enterography for Crohn's Disease: A Patient's Guide
MR enterography for Crohn's disease is a radiation-free scan that maps small bowel inflammation. Learn how MRE works, what to expect, and why it matters.

Top-Down vs Step-Up Therapy for Crohn's: PROFILE Trial
PROFILE trial shows top-down therapy for Crohn's disease beats step-up: 79% sustained remission vs 15% at one year. What newly diagnosed patients need to know.

Subcutaneous Infliximab (Zymfentra) for Crohn's Disease
Subcutaneous infliximab (Zymfentra) is the first FDA-approved self-injection biologic for Crohn's disease. Learn how it works, who it fits, trial data.